BDSX Q1 2025 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q1 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$18M+21.2% YoY

Gross Profit

$14M79.4% margin

Operating Income

-$9M-50.9% margin

Net Income

-$11M-61.8% margin

EPS (Diluted)

$-1.60

QoQ Revenue Growth

-12.1%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$972,000

Balance Sheet

Total Assets

$86M

Total Liabilities

$75M

Stockholders' Equity

$11M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$15M	+21.2%
Gross Profit	$14M	$12M	+22.4%
Operating Income	-$9M	-$11M	+17.1%
Net Income	-$11M	-$14M	+18.5%

Revenue Segments

Diagnostic Tests

$16M91%

Development Services

$2M9%